N

Numab Therapeutics AG

71 employees

Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.

Investor insights

Funding rounds participated in

$15M sweet spot round size

Most of their 1 investments are in rounds between $15M and $15M

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Diagnostics
Health Care
Therapeutics
Medical
Biopharma
Life Science

Date founded

2011

Investments made

U

Undisclosed raised $15M on December 12, 2019

Investors: Numab Therapeutics AG

Funding rounds raised

Total raised

$111M

from 6 investors over 6 rounds

N

Numab Therapeutics AG raised $111M on May 19, 2021

Investors: RTW Investments, LP, Novo Holdings, Forbion, Octagon Capital Advisors and HBM Partners AG

N

Numab Therapeutics AG raised $22M on December 12, 2019

Investors: Eisai Asia

FAQ